Trauma Relief Gel
- Manufacturer
- Deseret Biologicals | Apotheca Company
- Effective date
- 2016-03-08
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 01:28:02
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
ACTIVE INGREDIENTS:
Chamomilla 3X, Echinacea 3X, Hamamelis Virginiana 3X, Hypericum Perforatum 3X, Millefolium 3X, Bryonia (Alba) 4X, Calendula Officinalis 4X, Symphytum Officinale 4X, Arnica Montana 4X, Belladonna 6X, Bellis Perennis 6X, Clematis Vitalba, Flos 6X, Helianthemum Nummularium Flos 6X, Impatiens Glandulifera Flos 6X, Ornithogalum Umbellatum Flos 6X, Prunus Cerasifera Flos 6X, Rhus Tox 6X, Hepar Sulphuris Calcareum 8X, Carbo Vegetabilis 12X.
INDICATIONS:
For the temporary relief of strains, sprains, contusions, fractures and joint pain.
WARNINGS:
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
If pregnant or breast-feeding, seek advice of a health professional before use.
Do not use if seal is broken or missing.
For external use only, not for oral use.
Do not expose to extreme heat.
SUGGESTED APPLICATION:
Apply a small amount on the area of discomfort, gently rubbing the gel into the skin. Application should be as soon after the injury as possible. Repeat three times in 10 minute intervals; thereafter apply three times daily as needed.
INACTIVE INGREDIENTS:
Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Aloe Barbadensis Leaf Juice, Benzylalcohol-DHA, Demineralized Water, Glycerin, Glycine, Hyaluronic Acid, L-Arginine Base, L-Aspartic Acid, Sodium PCA.
KEEP OUT OF REACH OF CHILDREN:
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
INDICATIONS:
For the temporary relief of strains, sprains, contusions, fractures and joint pain.
QUESTIONS:
PACKAGE LABEL DISPLAY:
DESBIO
NDC 43742-0322-1
HOMEOPATHIC
TRAUMA RELIEF GEL
With Aloe Vera
NET WT 4.45 OZ (126 G)
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ACTIVATED CHARCOAL | ACTIVE INGREDIENT | 2P3VWU3H10 | 2 | |
| ARNICA MONTANA | ACTIVE INGREDIENT | O80TY208ZW | 2 | |
| ATROPA BELLADONNA WHOLE | ACTIVE INGREDIENT | DSV74G1P2J | 2 | |
| BELLIS PERENNIS | ACTIVE INGREDIENT | 2HU33I03UY | 2 | |
| BRYONIA ALBA ROOT | ACTIVE INGREDIENT | T7J046YI2B | 2 | |
| CALCIUM SULFIDE | ACTIVE INGREDIENT | 1MBW07J51Q | 2 | |
| CALENDULA OFFICINALIS FLOWERING TOP | ACTIVE INGREDIENT | 18E7415PXQ | 2 | |
| CLEMATIS VITALBA FLOWER | ACTIVE INGREDIENT | 7SCP4N87CI | 2 | |
| COMFREY ROOT | ACTIVE INGREDIENT | M9VVZ08EKQ | 2 | |
| ECHINACEA ANGUSTIFOLIA | ACTIVE INGREDIENT | VB06AV5US8 | 2 | |
| HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK | ACTIVE INGREDIENT | T7S323PKJS | 2 | |
| HELIANTHEMUM NUMMULARIUM FLOWER | ACTIVE INGREDIENT | 51BRR32WPP | 2 | |
| HYPERICUM PERFORATUM | ACTIVE INGREDIENT | XK4IUX8MNB | 2 | |
| IMPATIENS GLANDULIFERA FLOWER | ACTIVE INGREDIENT | AJU5O1A5ZV | 2 | |
| MATRICARIA RECUTITA | ACTIVE INGREDIENT | G0R4UBI2ZZ | 2 | |
| ORNITHOGALUM UMBELLATUM FLOWERING TOP | ACTIVE INGREDIENT | CZD6M4PY4B | 2 | |
| PRUNUS CERASIFERA FLOWER | ACTIVE INGREDIENT | 0KD7R09EAS | 2 | |
| TOXICODENDRON PUBESCENS LEAF | ACTIVE INGREDIENT | 6IO182RP7A | 2 | |
| ACTIVATED CHARCOAL | ACTIVE MOIETY | 2P3VWU3H10 | 2 | |
| ARNICA MONTANA | ACTIVE MOIETY | O80TY208ZW | 2 | |
| ATROPA BELLADONNA WHOLE | ACTIVE MOIETY | DSV74G1P2J | 2 | |
| BELLIS PERENNIS | ACTIVE MOIETY | 2HU33I03UY | 2 | |
| BRYONIA ALBA ROOT | ACTIVE MOIETY | T7J046YI2B | 2 | |
| CALCIUM SULFIDE | ACTIVE MOIETY | 1MBW07J51Q | 2 | |
| CALENDULA OFFICINALIS FLOWERING TOP | ACTIVE MOIETY | 18E7415PXQ | 2 | |
| CLEMATIS VITALBA FLOWER | ACTIVE MOIETY | 7SCP4N87CI | 2 | |
| COMFREY ROOT | ACTIVE MOIETY | M9VVZ08EKQ | 2 | |
| ECHINACEA ANGUSTIFOLIA | ACTIVE MOIETY | VB06AV5US8 | 2 | |
| HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK | ACTIVE MOIETY | T7S323PKJS | 2 | |
| HELIANTHEMUM NUMMULARIUM FLOWER | ACTIVE MOIETY | 51BRR32WPP | 2 | |
| HYPERICUM PERFORATUM | ACTIVE MOIETY | XK4IUX8MNB | 2 | |
| IMPATIENS GLANDULIFERA FLOWER | ACTIVE MOIETY | AJU5O1A5ZV | 2 | |
| MATRICARIA RECUTITA | ACTIVE MOIETY | G0R4UBI2ZZ | 2 | |
| ORNITHOGALUM UMBELLATUM FLOWERING TOP | ACTIVE MOIETY | CZD6M4PY4B | 2 | |
| PRUNUS CERASIFERA FLOWER | ACTIVE MOIETY | 0KD7R09EAS | 2 | |
| TOXICODENDRON PUBESCENS LEAF | ACTIVE MOIETY | 6IO182RP7A | 2 | |
| ALOE VERA LEAF | INACTIVE INGREDIENT | ZY81Z83H0X | 2 | |
| ARGININE | INACTIVE INGREDIENT | 94ZLA3W45F | 2 | |
| ASPARTIC ACID | INACTIVE INGREDIENT | 30KYC7MIAI | 2 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | 2 | |
| CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED) | INACTIVE INGREDIENT | 59TL3WG5CO | 2 | |
| DEHYDROABIETIC ACID | INACTIVE INGREDIENT | 0S5XP6S3AU | 2 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 2 | |
| GLYCINE | INACTIVE INGREDIENT | TE7660XO1C | 2 | |
| HYALURONIC ACID | INACTIVE INGREDIENT | S270N0TRQY | 2 | |
| SODIUM PYRROLIDONE CARBOXYLATE | INACTIVE INGREDIENT | 469OTG57A2 | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Products#
Every source-derived product name is available through these pages.
- Trauma Relief Gel
- Chamomilla, Echinacea, Hamamelis Virginiana, Hypericum Perforatum, Millefolium, Bryonia (Alba), Calendula Officinalis, Symphytum Officinale, Arnica Montana, Belladonna, Bellis Perennis, Clematis Vitalba, Flos, Helianthemum Nummularium Flos, Impatiens Glandulifera Flos, Ornithogalum Umbellatum Flos, Prunus Cerasifera Flos, Rhus Tox, Hepar Sulphuris Calcareum, Carbo Vegetabilis
- MATRICARIA RECUTITA
- ECHINACEA ANGUSTIFOLIA
- HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK
- HYPERICUM PERFORATUM
- BRYONIA ALBA ROOT
- CALENDULA OFFICINALIS FLOWERING TOP
- COMFREY ROOT
- ARNICA MONTANA
- ATROPA BELLADONNA WHOLE
- BELLIS PERENNIS
- CLEMATIS VITALBA FLOWER
- HELIANTHEMUM NUMMULARIUM FLOWER
- IMPATIENS GLANDULIFERA FLOWER
- ORNITHOGALUM UMBELLATUM FLOWERING TOP
- PRUNUS CERASIFERA FLOWER
- TOXICODENDRON PUBESCENS LEAF
- CALCIUM SULFIDE
- ACTIVATED CHARCOAL
- CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED)
- ALOE VERA LEAF
- BENZYL ALCOHOL
- DEHYDROABIETIC ACID
- WATER
- GLYCERIN
- GLYCINE
- HYALURONIC ACID
- ARGININE
- ASPARTIC ACID
- SODIUM PYRROLIDONE CARBOXYLATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 43742-0322 | 43742-0322-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | SUSPENSION / TOPICAL | 1 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | SPRAY, METERED / NASAL | 5 mg/1ml | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY | 8.4 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | SOLUTION / TOPICAL | 2 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, EXTENDED RELEASE / ORAL | 7 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 200 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION, SUSPENSION / INTRAMUSCULAR | 40 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 10 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | CREAM / VAGINAL | 1 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION / INTRACAVITARY | 0.01 ml | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTION, SOLUTION / INTRAVENOUS | 0.42 %w/v | ||
| GLYCINE | GLYCINE | TE7660XO1C | TABLET / ORAL | 163.31 mg | ||
| ARGININE | ARGININE | 94ZLA3W45F | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | 6240 mg | ||
| ARGININE | ARGININE | 94ZLA3W45F | POWDER, FOR SOLUTION / INTRAVENOUS | 7.07 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVERNOUS | 18 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION / INTRAMUSCULAR | 1000 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTION / INTRAVENOUS | 200 mg | ||
| ARGININE | ARGININE | 94ZLA3W45F | TABLET, FILM COATED / ORAL | 25 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTION, POWDER, FOR SOLUTION / INTRADERMAL | 0.5 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / PERIODONTAL | 0.53 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | LOTION / TOPICAL | 4000 mg | ||
| ARGININE | ARGININE | 94ZLA3W45F | INJECTION / INTRAVENOUS | 790 mg | ||
| ARGININE | ARGININE | 94ZLA3W45F | INJECTION, SOLUTION / INTRAVENOUS | 0.29 %w/v | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION / INTRAVENOUS | 1620 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION, SOLUTION / INTRA-ARTICULAR | 23 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION / INTRALESIONAL | 23 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | 3822 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | GEL / RECTAL | 124 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | SUSPENSION / AURICULAR (OTIC) | 0.9 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| ASPARTIC ACID | ASPARTIC ACID | 30KYC7MIAI | INJECTION / INTRAVENOUS | 22 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 3.76 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | OINTMENT / TOPICAL | 2.2 %w/w | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 144 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| c92b2029-d418-49b7-a7de-fe4943009080 | 6607424a-9e23-43c3-a3d5-1d58fa9f1e88 | 2016-03-08 | Warnings | c92b2029-d418-49b7-a7de-fe4943009080 6607424a-9e23-43c3-a3d5-1d58fa9f1e88 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
